----
Current Valuation
-9.25xP/E
HK$22.60Stock price
HK$-2.44Earnings per share
-9.25xP/E
Stock priceHK$22.60Earnings per shareHK$-2.44
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.66x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.66x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
02335HKMICOT PHARMA-B | -64.88x | -- | HK$13.11B |
06872HKTENNOR THERAP-B | -74.76x | -- | HK$12.68B |
02630HKVIGONVITA-B | -25.11x | -- | HK$9.89B |
09637HKALEBUND-B | -9.25x | -- | HK$7.68B |
00570HKTRAD CHI MED | -17.82x | 310.14% | HK$6.75B |
02575HKXUANZHUBIO-B | -24.35x | -- | HK$6.62B |
01477HKOCUMENSION-B | -20.17x | 120.44% | HK$3.55B |
06915HKJIANGXI BIO | -- | -- | HK$3.45B |
01349HKFUDANZHANGJIANG | -13.57x | -- | HK$2.34B |
06996HKANTENGENE-B | -8.47x | 234.26% | HK$2.24B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
